Spire Healthcare Group PLC (SPI.L) stock: key figures, P/E, revenue and dividend
Health Care · United Kingdom · ISIN GB00BNLPYF73
Spire Healthcare Group PLC financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.51 bn GBP | 1.58 bn GBP |
| Gross profit | 683.00 m GBP | 599.10 m GBP |
| Operating income | – | 146.10 m GBP |
| EBIT | 141.00 m GBP | – |
| Net income | 25.00 m GBP | 16.40 m GBP |
| Diluted EPS – continuing operations | 0.06 GBP | 0.04 GBP |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Spire Healthcare Group PLC
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
More stocks
- Riyue Heavy Industry Co Ltd (603218.SS)
- Valeura Energy Inc (VLE.TO)
- Vanchip (Tianjin) Technology Co. Ltd. A (688153.SS)
- Ratos AB (RATO B.ST)
- Lotus Pharmaceutical Co Ltd (1795.TW)
- Pacific Shuanglin Bio pharmacy Co Ltd (000403.SZ)
- Nutex Health Inc. (NUTX)
- MEDICAL PROPERTIES TRUST INC (MPT)
- HERBALIFE LTD. (HLF)
- Scientex Bhd (4731.KL)
- Lotte Rental Co Ltd (089860.KS)
- Turning Point Brands, Inc. (TPB)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.